# A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain

> **NCT07326137** · — · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 103 (estimated)

## Conditions studied

- Advanced Biliary Tract Cancer(BTC)
- Advanced Pancreatic Cancers
- Cancer-related Pain

## Interventions

- **DRUG:** First-Line Systemic Therapy
- **PROCEDURE:** Celiac Plexus Neurolysis (CPN)

## Key facts

- **NCT ID:** NCT07326137
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-26
- **Primary completion:** 2028-06-26
- **Final completion:** 2028-12-26
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07326137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07326137, "A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07326137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*